2024-03-29T13:58:19Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_67CDAECEFF08
2024-03-23T02:28:39Z
serval:BIB_67CDAECEFF08
Rhumatologie. Une nouvelle option thérapeutique dans la prise en charge de l'inflammation chronique en rhumatologie: les inhibiteurs des janus kinases [A new therapeutical option for chronic inflammation in rheumatology: janus kinases inhibitors (JAK)].
24624736
Varisco
P.A.
author
So
A.
author
article
review
2014
Revue Médicale Suisse
1660-9379
1660-9379
journal
10
414
187-191
Antirheumatic Agents/adverse effects
Antirheumatic Agents/pharmacology
Arthritis, Rheumatoid/drug therapy
Arthritis, Rheumatoid/enzymology
Chronic Disease
Drug Approval
Humans
Inflammation/drug therapy
Inflammation/enzymology
Janus Kinases/antagonists & inhibitors
Piperidines/adverse effects
Piperidines/pharmacology
Protein Kinase Inhibitors/adverse effects
Protein Kinase Inhibitors/pharmacology
Pyrimidines/adverse effects
Pyrimidines/pharmacology
Pyrroles/adverse effects
Pyrroles/pharmacology
Rheumatic Diseases/drug therapy
Rheumatic Diseases/enzymology
hic" UI="D013557">Switzerland
fre
60_published
Publication types: English Abstract ; Journal Article Publication Status: ppublish